With more than 1.2 million Americans with Type 1 diabetes, and 40,000 more diagnosed every year, the manufacturers of synthetic insulin are the epitome of job security. But why is the expense of insulin so burdensome to those living with Type 1 diabetes? In this fascinating talk, Connor Behr explains the current method of producing synthetic insulin and offers hope for a better solution that is more efficient and less costly, in more ways than one. Connor Behr is currently a student at BYU PathwayConnect in pursuit of a degree in molecular biology, which he has loved and studied since he was 12 years old. He is skilled in the field and has experience shadowing at ARUP Laboratories and a summer internship at the Huntsman Cancer Institute. Connor received the Emperor Science Award in 2017 for his research in cancer development and treatment, and he conducted related gene and protein expression projects with Physarum polycephalum, an organism he has been studying for more than 9 years. He is currently heading a campaign called the PhyR Project for the development of an alternative insulin production technique. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at
With more than 1.2 million Americans with Type 1 diabetes, and 40,000 more diagnosed every year, the manufacturers of synthetic insulin are the epitome of job security. But why is the expense of insulin so burdensome to those living with Type 1 diabetes? In this fascinating talk, Connor Behr explains the current method of producing synthetic insulin and offers hope for a better solution that is more efficient and less costly, in more ways than one. Connor Behr is currently a student at BYU PathwayConnect in pursuit of a degree in molecular biology, which he has loved and studied since he was 12 years old. He is skilled in the field and has experience shadowing at ARUP Laboratories and a summer internship at the Huntsman Cancer Institute. Connor received the Emperor Science Award in 2017 for his research in cancer development and treatment, and he conducted related gene and protein expression projects with Physarum polycephalum, an organism he has been studying for more than 9 years. He is currently heading a campaign called the PhyR Project for the development of an alternative insulin production technique. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at
0 Comments